Drug
GW 1000 02
GW 1000 02: highest development phase Phase 3, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| GW-1000-02 NCT01606202 | Phase 3 | Pain |
Latest
No recent events.
Follow GW 1000 02 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.